XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.23.1

Earnings (Loss) per Ordinary Share | 3 Months Ended
--- | ---
Mar. 31, 2023
Earnings Per Share [Abstract] |
Earnings (Loss) per Ordinary Share | Earnings per ShareBasic earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive. Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:
|  |  | Three Months Ended
|  |  | March 31,
(In millions, except per share amounts) |  |  |  |  | 2023 |  | 2022
Basic earnings attributable to Viatris Inc. common shareholders |  |  |  |  |  |  |
Net earnings attributable to Viatris Inc. common shareholders |  |  |  |  | $ | 224.7 |  |  | $ | 399.2 |
Shares (denominator): |  |  |  |  |  |  |
Weighted average shares outstanding |  |  |  |  | 1,202.5 |  |  | 1,210.5 |
Basic earnings per share attributable to Viatris Inc. shareholders |  |  |  |  | $ | 0.19 |  |  | $ | 0.33 |
Diluted earnings attributable to Viatris Inc. common shareholders |  |  |  |  |  |  |
Net earnings attributable to Viatris Inc. common shareholders |  |  |  |  | $ | 224.7 |  |  | $ | 399.2 |
Shares (denominator): |  |  |  |  |  |  |
Weighted average shares outstanding |  |  |  |  | 1,202.5 |  |  | 1,210.5 |
Share-based awards |  |  |  |  | 3.1 |  |  | 2.6 |
Total dilutive shares outstanding |  |  |  |  | 1,205.6 |  |  | 1,213.1 |
Diluted earnings per share attributable to Viatris Inc. shareholders |  |  |  |  | $ | 0.19 |  |  | $ | 0.33 |
Additional stock awards and Restricted Stock Awards were outstanding during the three months ended March 31, 2023 and 2022, but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares at March 31, 2023 include certain share-based compensation awards whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 13.9 million shares and 15.5 million shares for the three months ended March 31, 2023 and 2022, respectively. The Company paid a quarterly dividend of $0.12 per share on the Company’s issued and outstanding common stock on March 17, 2023. On May 5, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company’s issued and outstanding common stock, which will be payable on June 16, 2023 to shareholders of record as of the close of business on May 24, 2023. The declaration and payment of future dividends to holders of the Company’s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company’s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant. On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the three months ended March 31, 2023, the Company repurchased approximately 21.2 million shares of common stock at a cost of approximately $250 million. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration